Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Subscribe To Our Newsletter & Stay Updated
